Latest Update (as of September 28, 2026): On September 14, 2026, a Missouri state judge heard arguments on whether to give final approval to Bayer’s proposed $7.25 billion Roundup class settlement. Judge Timothy Boyer did not rule from the bench and invited additional filings, and we have found no report of a final decision since. Until he rules, the settlement remains a proposal, and claim registration stays closed. This follows the U.S. Supreme Court’s June 2026 decision in Monsanto v. Durnell, which sided with Bayer on state-law failure-to-warn claims. Check back for updates once the court decides.
Last updated: September 2026
The Monsanto Roundup lawsuit is one of the largest mass tort cases in American legal history, and it is not over yet. Tens of thousands of people who used Roundup weedkiller and later developed cancer are still fighting for compensation in 2026.
Bayer, which acquired Monsanto in 2018, has paid out billions in settlements. But new claims are still being filed and accepted. Courts are still active.
If you or someone you know used Roundup regularly and received a cancer diagnosis, this guide will tell you exactly where things stand, whether you still qualify, and what your next step looks like.
One number that puts this in perspective: Bayer has set aside approximately $16 billion to resolve Roundup-related claims across the United States. That figure alone tells you how serious this litigation is.
Monsanto Roundup Lawsuit: What This Case Is Actually About
The Monsanto Roundup lawsuit is a mass tort action claiming that Monsanto’s weedkiller Roundup caused cancer in people who used it, and that Monsanto knew about the risk but failed to warn consumers.
Roundup’s active ingredient is glyphosate, an herbicide used in agriculture and residential gardening for decades. In 2015, the World Health Organization’s cancer research arm, the International Agency for Research on Cancer (IARC), classified glyphosate as “probably carcinogenic to humans.”
That classification sparked a wave of lawsuits. Plaintiffs argued Monsanto had internal research showing the risks and buried it.
The most common cancer linked to Roundup exposure is Non-Hodgkin’s lymphoma, a cancer of the lymphatic system. Several types of lymphoma have appeared in court filings as qualifying diagnoses.
| Key Case Facts | Details |
|---|---|
| Product at Issue | Roundup weedkiller (glyphosate) |
| Chemical Flagged | Glyphosate |
| IARC Classification | Probably carcinogenic to humans (Group 2A, 2015) |
| Primary Cancer Claimed | Non-Hodgkin’s lymphoma |
| Defendant | Monsanto (now owned by Bayer AG) |
| MDL Docket | MDL 2741, N.D. California |
Roundup Lawsuit Update 2026: Where Things Stand Right Now
The Roundup litigation entered a new phase in 2026. It is still very much active, though the structure of the litigation has shifted.
Bayer reached a broad settlement agreement in 2020 to resolve the bulk of existing claims. That deal, valued at approximately $10.9 billion, covered over 100,000 plaintiffs. But new lawsuits have continued to emerge from people who either did not join the earlier settlement or were diagnosed after it was structured.
The U.S. Supreme Court’s 2024 decision in the Roundup preemption dispute sent shockwaves through the case landscape. The Court declined to fully shield Bayer from state law failure-to-warn claims. That ruling kept the door open for new plaintiffs to argue their cases under state product liability laws.
In 2026, individual bellwether trials are still being scheduled in California federal court. Bayer is simultaneously negotiating with plaintiff attorneys over how to structure future claim resolutions.
| 2026 Litigation Status | Status |
|---|---|
| MDL 2741 Active | Yes |
| New Claims Accepted | Yes (criteria apply) |
| Active Trials Scheduled | Yes, individual cases in California |
| Bayer Settlement Fund Active | Partially, fund ongoing |
| Supreme Court Preemption Shield | Denied for state law claims |
Bayer Monsanto Roundup Lawsuit: How Bayer Became the Defendant
Bayer became the face of the Roundup lawsuit when it acquired Monsanto in June 2018 for approximately $63 billion. That purchase included full legal liability for Monsanto’s products, including Roundup.
Bayer leadership has publicly acknowledged that the acquisition came with serious legal baggage. By the time the deal closed, thousands of Roundup lawsuits were already filed or pending.
Since 2018, Bayer has lost multiple high-profile jury verdicts. The most notable early verdict was the Dewayne Johnson case in 2018, where a California jury awarded $289 million in damages (later reduced on appeal). Johnson, a school groundskeeper, argued Roundup caused his Non-Hodgkin’s lymphoma.
Bayer has maintained throughout this litigation that glyphosate is safe when used as directed. The company points to EPA’s own assessments, which have generally not classified glyphosate as a human carcinogen. That scientific dispute is central to every trial.
| Bayer’s Roundup Legal Timeline | Year |
|---|---|
| Monsanto acquisition by Bayer | 2018 |
| First major jury verdict (Johnson v. Monsanto) | 2018 |
| Broad settlement agreement announced | 2020 |
| Supreme Court preemption ruling | 2024 |
| Active individual trials continue | 2026 |
Key Takeaway: Bayer assumed full legal responsibility for Monsanto’s Roundup lawsuits in 2018, and despite a massive settlement fund, new individual trials are still proceeding through federal court in 2026.
Roundup Lawsuit Settlement Amounts 2026: What Plaintiffs Are Being Paid
Roundup lawsuit settlement amounts in 2026 range widely, from under $100,000 to over $2 million, depending on the strength of the individual claim.
The $10.9 billion Bayer settlement fund announced in 2020 did not pay every plaintiff the same amount. Instead, it used a matrix-style system that factored in cancer type, cancer severity, age at diagnosis, duration of exposure to Roundup, and other individual factors.
Think of it like an insurance adjuster scoring a claim. The more serious the diagnosis and the more clearly exposure is documented, the higher the valuation.
| Settlement Tier Factors | Impact on Payout |
|---|---|
| Cancer type (e.g., diffuse large B-cell lymphoma) | Higher severity, higher payout |
| Cancer stage at diagnosis | Advanced stage increases award |
| Age at diagnosis | Younger plaintiff, higher lifetime impact |
| Years of Roundup exposure | Longer exposure strengthens claim |
| Prior claim resolution or dismissal | May affect eligibility for new fund |
Early jury verdicts produced far larger numbers: $80 million, $289 million, even a $2 billion punitive damages verdict (later reduced). Those numbers reflect what juries thought Monsanto deserved to pay, not what the settlement fund averages.
For plaintiffs settling through the fund in 2026, realistic expectations for a serious lymphoma case with documented exposure fall in the $150,000 to $500,000 range for most claimants.
Who Qualifies for the Roundup Lawsuit in 2026
You likely qualify for the Roundup lawsuit if you used Roundup weedkiller regularly and were later diagnosed with Non-Hodgkin’s lymphoma or a related cancer.
“Regularly” generally means repeated or prolonged use, not a single one-time application. Courts and plaintiff attorneys look at occupational exposure (farmers, landscapers, groundskeepers) as the strongest cases. But residential users with years of consistent use have also qualified.
The diagnosis must be a cancer of the lymphatic system in most cases. Specific diagnoses that have appeared in qualifying case filings include:
- Diffuse large B-cell lymphoma
- Follicular lymphoma
- Mantle cell lymphoma
- Marginal zone lymphoma
- Chronic lymphocytic leukemia (in certain filings)
- Hairy cell leukemia (accepted in some MDL cases)
There is no official income threshold or geographic restriction. Plaintiffs have come from every U.S. state.
Key Takeaway: Qualifying for the Roundup lawsuit in 2026 generally requires documented repeated exposure to Roundup and a medical diagnosis of Non-Hodgkin’s lymphoma or a closely related lymphatic cancer.
Roundup Lawsuit Eligibility Requirements: The Full Checklist
Eligibility for the Roundup lawsuit in 2026 depends on meeting several specific criteria reviewed by plaintiff attorneys before a case is accepted.
Courts do not process individual claims without attorney representation in this type of mass tort. Plaintiff attorneys evaluate potential clients against a standard checklist before agreeing to take a case.
Here is what the eligibility review typically examines:
| Eligibility Factor | Requirement |
|---|---|
| Roundup Use | Must have used Roundup personally (not just nearby) |
| Frequency of Use | Regular, repeated use over months or years |
| Diagnosis | Non-Hodgkin’s lymphoma or qualifying related cancer |
| Diagnosis Date | Generally any date, though statute of limitations applies |
| Medical Records | Required to document diagnosis |
| Purchase or Use Records | Helpful but not always required |
| U.S. Residency | Must have used Roundup in the United States |
The most rejected cases involve people who used Roundup only once or twice, people whose cancer diagnosis is unrelated to lymphatic conditions, or people whose statute of limitations has expired under their state’s laws.
If you are unsure whether your situation qualifies, the safest approach is to contact a plaintiff attorney who handles toxic tort cases. Most do free case evaluations for Roundup claims.
Roundup Non-Hodgkin’s Lymphoma Lawsuit: The Medical Evidence Behind the Claims
Non-Hodgkin’s lymphoma is the primary cancer at the center of the Roundup lawsuit, and the medical research supporting the link is what makes these cases winnable.
In 2015, the IARC classified glyphosate as a Group 2A probable human carcinogen. That conclusion was based on studies showing statistical associations between glyphosate exposure and Non-Hodgkin’s lymphoma in agricultural workers.
Internal Monsanto documents, revealed during discovery, showed company scientists discussing how to manage and counter independent research that found glyphosate concerning. Juries in California found those internal communications deeply damaging to Monsanto’s defense.
Non-Hodgkin’s lymphoma is not a single cancer. It is a family of cancers affecting lymphocytes, a type of white blood cell. The disease has subtypes that vary in aggressiveness. Diffuse large B-cell lymphoma and follicular lymphoma are the most commonly cited in Roundup litigation.
| NHL Type | Appearance in Roundup Litigation |
|---|---|
| Diffuse large B-cell lymphoma | Most common, frequently cited in trial verdicts |
| Follicular lymphoma | Frequently accepted in MDL filings |
| Mantle cell lymphoma | Accepted with documented exposure history |
| Hairy cell leukemia | Accepted in select MDL cases |
| Chronic lymphocytic leukemia | Case-by-case review required |
Key Takeaway: The link between glyphosate and Non-Hodgkin’s lymphoma is backed by a 2015 IARC classification, epidemiological research, and internal Monsanto documents revealed in discovery, all of which have been central to jury verdicts against the company.
Roundup Lawsuit Payout Per Person: Realistic Numbers for 2026 Claimants
The average Roundup lawsuit payout per person through the settlement fund falls in the range of $5,000 to $250,000 for typical individual claims, with severe or high-exposure cases settling considerably higher.
This is a range that surprises many people who hear about the billion-dollar jury verdicts. The difference is this: jury verdicts are maximums awarded in contested trials. Settlement fund payouts are negotiated averages designed to resolve thousands of claims efficiently.
Think of it the way insurance companies handle car accident settlements. A single lawsuit might win a huge verdict at trial, but the same insurer processes thousands of routine claims at standard rates.
| Payout Category | Estimated Range |
|---|---|
| Minor exposure, lower severity diagnosis | $5,000 to $50,000 |
| Moderate exposure, confirmed NHL diagnosis | $50,000 to $150,000 |
| Strong occupational exposure, serious NHL | $150,000 to $500,000 |
| Exceptional cases (jury trial) | $1 million and above |
| Punitive damages (trial only) | Varies, historically much higher |
Plaintiffs who opt out of the settlement fund and pursue individual trials take on more risk, but potentially much higher rewards. Most attorneys counsel clients toward settlements unless the case facts are exceptionally strong.
Bayer Roundup Settlement Fund: How the Money Is Structured
The Bayer Roundup settlement fund is a $10.9 billion resolution vehicle announced in June 2020 to resolve over 100,000 existing claims filed against Monsanto before that date.
The fund was not a class action settlement. Each plaintiff’s claim was valued individually using a scoring matrix developed by Bayer and plaintiffs’ lead counsel. The matrix weighted factors like cancer type, exposure history, age, and medical outcome.
A separate $1.25 billion component was set aside to handle future claimants who had not yet been diagnosed at the time of the settlement, or who filed claims after the primary fund was established.
| Settlement Fund Component | Amount |
|---|---|
| Primary resolution fund (100K+ claims) | $9.6 billion |
| Future claimants reserve | $1.25 billion |
| Total announced settlement value | $10.9 billion (reported) |
| Additional Bayer legal reserves (2024 onward) | Additional billions set aside |
Not every plaintiff accepted the fund terms. Some opted out to pursue trial. Bayer has continued to face new trials from opt-out plaintiffs, producing new verdicts in 2024 and into 2025.
Key Takeaway: Bayer’s $10.9 billion settlement fund resolved the majority of Roundup claims filed before 2020, but a separate future claimants reserve and ongoing individual trials mean the financial exposure for Bayer is still growing in 2026.
Is the Roundup Lawsuit Still Active in 2026?
Yes, the Roundup lawsuit is still active in 2026. New cases are being filed, individual trials are still being scheduled, and courts continue to issue rulings that shape how this litigation unfolds.
MDL 2741 in the Northern District of California remains the central federal coordination docket for Roundup cases. Judge Vince Chhabria has continued to manage the case load, which still includes thousands of unresolved claims.
Beyond the MDL, Roundup cases are also litigated in state courts across the country, including California, Missouri, and Florida. State courts apply different legal standards, and some have produced plaintiff-friendly verdicts.
The 2024 Supreme Court ruling was a critical moment. The Court declined to preempt state failure-to-warn claims, meaning plaintiffs can still argue under state law that Monsanto failed to warn them of glyphosate’s cancer risk, even if federal law did not require such warnings at the time.
| Litigation Activity in 2026 | Status |
|---|---|
| MDL 2741 active | Yes |
| New individual trials scheduled | Yes |
| New claims being accepted | Yes |
| State court cases active | Yes |
| Bayer seeking new global resolution | Ongoing negotiations |
Glyphosate Cancer Lawsuit: The Science Bayer Cannot Ignore
The glyphosate cancer lawsuit hinges on one central scientific dispute: whether glyphosate causes cancer in humans at real-world exposure levels.
The IARC says glyphosate is “probably carcinogenic.” The U.S. EPA has maintained for years that glyphosate is “not likely to be carcinogenic to humans” when used as directed. That gap between international and domestic regulatory positions is exactly where litigation lives.
Plaintiff attorneys have used the IARC classification, combined with independent epidemiological studies, to argue the cancer link is scientifically sound. Defense attorneys point to EPA conclusions and argue that farmers worldwide have used glyphosate safely for decades.
What has tilted juries toward plaintiffs in key cases is the internal Monsanto document evidence. Emails and memos revealed in discovery showed Monsanto scientists and public relations staff working to shape and discredit independent research rather than conduct neutral safety studies.
| Scientific Position | Source | Conclusion |
|---|---|---|
| Probably carcinogenic (Group 2A) | IARC / WHO (2015) | Supports plaintiffs |
| Not likely carcinogenic | U.S. EPA | Supports Bayer defense |
| Epidemiological studies | Multiple independent researchers | Mixed, but some find associations |
| Internal Monsanto documents | Discovery evidence | Found damaging by multiple juries |
Key Takeaway: The glyphosate cancer lawsuit rests on a genuine scientific dispute between the WHO’s cancer agency and the U.S. EPA, with internal Monsanto communications serving as some of the most powerful evidence in favor of plaintiffs at trial.
Roundup Weedkiller Cancer Lawsuit: Who Has Already Won and What They Were Paid
The Roundup weedkiller cancer lawsuit has already produced some of the largest personal injury verdicts in American history, establishing clear precedent for what juries think about Monsanto’s conduct.
The three landmark early verdicts made headlines worldwide. Each was reduced on appeal, but each also survived challenges to liability, meaning the core finding that Roundup caused cancer and that Monsanto failed to warn was upheld.
| Plaintiff | Original Verdict | Post-Appeal Amount | Diagnosis |
|---|---|---|---|
| Dewayne Johnson | $289 million (2018) | $78.5 million | Non-Hodgkin’s lymphoma |
| Edwin Hardeman | $80 million (2019) | $25 million | Non-Hodgkin’s lymphoma |
| Pilliod couple (joint) | $2.055 billion (2019) | $86.7 million | Non-Hodgkin’s lymphoma (both plaintiffs) |
These verdicts sent a clear signal: juries believe Roundup causes cancer. They also believe Monsanto acted with malice or reckless disregard. That malice finding is what triggers punitive damages, which explains the massive original numbers.
For new plaintiffs in 2026, these verdicts provide a legal foundation. They do not guarantee a specific payout, but they demonstrate that courts and juries have consistently sided with Roundup cancer plaintiffs when the evidence is presented properly.
Roundup Lawsuit New Cases Accepted in 2026: Can You Still File?
New Roundup cases are still being accepted in 2026, and plaintiff attorneys are actively reviewing new inquiries from people who used Roundup and were later diagnosed with cancer.
Cases filed now fall outside the original settlement fund that closed for pre-2020 plaintiffs. New claimants are evaluated for the future claimants reserve or for individual litigation, depending on their case facts.
The key question for new plaintiffs is always the statute of limitations. Each state has its own time limit for filing personal injury claims. In most states, that window is 2 to 3 years from the date you knew or reasonably should have known that your cancer was linked to Roundup use.
| New Case Acceptance Factors | What Matters |
|---|---|
| Roundup use documented | Essential |
| NHL or related cancer diagnosed | Required |
| State statute of limitations | Must not be expired |
| Medical records available | Required |
| Prior claim or settlement | Must not have released claims |
If you were recently diagnosed or only recently connected your diagnosis to Roundup, you may still be within your filing window. The clock typically starts when you became aware of the possible connection, not necessarily the diagnosis date.
Key Takeaway: New Roundup cases are still being accepted in 2026, but the statute of limitations is the biggest risk for late filers. Each state’s time limit differs, and the clock may start from when you first connected your cancer to Roundup, not your diagnosis date.
Bayer Roundup Lawsuit News: Key Developments Heading Into 2026
The biggest Bayer Roundup lawsuit news heading into 2026 centers on three developments: continued individual trials, Bayer’s attempt to resolve future liability, and state-level regulatory shifts affecting new claims.
Bayer has repeatedly sought a global resolution that would cap future Roundup liability. Courts, however, have not been willing to impose a mandatory settlement that binds future plaintiffs who have not had their day in court. That tension between Bayer’s desire for certainty and plaintiffs’ rights has defined the litigation since 2020.
In 2024, Bayer lost additional jury trials in state courts, adding pressure for a more permanent resolution. Individual verdicts in 2024 ranged from $6.7 million to over $60 million before any appeals or reductions.
California, Missouri, and Philadelphia have been the most active trial venues. Each venue has its own jury pool characteristics, and plaintiff attorneys have become skilled at selecting favorable venues for the strongest cases.
| Recent Bayer Roundup News | Details |
|---|---|
| 2024 state court verdicts | Multiple losses for Bayer |
| Global resolution attempt | Ongoing, no final agreement as of 2026 |
| New MDL cases filed in 2025 to 2026 | Thousands still pending |
| Bayer stock impact | Repeated share price drops tied to verdicts |
| Congressional interest | Federal preemption legislation proposed, not passed |
Roundup Lawsuit Filing Deadline 2026: Do Not Miss Your Window
The Roundup lawsuit filing deadline varies by state, but for most U.S. plaintiffs the window to file is 2 to 3 years from the date of diagnosis or from the date a reasonable person would have connected their cancer to Roundup use.
This is the single most critical piece of information for anyone considering a claim. Miss the statute of limitations for your state, and your case is almost certainly gone, regardless of how strong it would otherwise be.
Some states apply what lawyers call the “discovery rule.” Under the discovery rule, the clock starts when you first knew or should have known that Roundup might have caused your cancer, not simply when you were diagnosed.
| State | Statute of Limitations (Approx.) |
|---|---|
| California | 2 years from discovery |
| Texas | 2 years from discovery |
| Florida | 4 years from discovery |
| New York | 3 years from discovery |
| Missouri | 5 years from discovery |
| Illinois | 2 years from discovery |
These timelines are general. Individual circumstances can extend or shorten the window. If you are close to what you think your deadline might be, treating it as urgent is the only rational response.
How to File a Roundup Lawsuit Claim in 2026
Filing a Roundup lawsuit claim in 2026 starts with contacting a plaintiff attorney who specializes in toxic tort or mass tort cases. You do not file directly with a court on your own.
The process moves through predictable stages. Knowing what to expect makes it far less intimidating. It is honestly simpler than most people assume once you have the right legal representation.
Here is how the process works, step by step:
Step 1: Initial Case Evaluation
A plaintiff attorney reviews your exposure history, diagnosis, and medical records. Most do this at no cost and on a contingency fee basis, meaning they only get paid if you win or settle.
Step 2: Case Documentation
Your attorney gathers medical records, purchase records if available, employment history for occupational exposure cases, and any other supporting documentation.
Step 3: Filing
Your attorney files your individual case, either into MDL 2741 in federal court or in a state court, depending on your situation and strategy.
Step 4: Discovery
Your case joins the broader discovery process. Evidence is exchanged between your legal team and Bayer’s defense attorneys.
Step 5: Settlement Evaluation or Trial
Your attorney advises you on any settlement offer Bayer makes. You decide whether to accept or proceed to trial.
| Filing Process Stage | Typical Timeline |
|---|---|
| Initial case evaluation | Days to weeks |
| Case documentation | 1 to 3 months |
| Filing into MDL or state court | After documentation complete |
| Discovery and litigation | 6 months to several years |
| Settlement or verdict | Varies widely |
The contingency fee structure in these cases typically runs 25% to 40% of any recovery. That fee covers all attorney costs out of the settlement or verdict amount. You pay nothing out of pocket upfront.
Frequently Asked Questions
Is the Monsanto Roundup lawsuit still accepting new claims in 2026?
Yes, the Roundup lawsuit is still actively accepting new claims in 2026.
New cases are being reviewed by plaintiff attorneys for individuals diagnosed with Non-Hodgkin’s lymphoma after using Roundup.
The main limitation is your state’s statute of limitations, which typically runs 2 to 3 years from when you connected your cancer to Roundup use.
How much money can I get from a Roundup lawsuit settlement?
Most settlement fund payouts for Roundup claims range from $5,000 to $500,000, depending on your diagnosis severity and exposure history.
Cases taken to trial have produced verdicts in the millions, but those outcomes are rarer and involve more risk.
The exact amount depends on your cancer type, how long you used Roundup, and other individual factors reviewed by the settlement valuation process.
What medical conditions qualify for the Roundup cancer lawsuit?
Non-Hodgkin’s lymphoma is the primary qualifying condition for the Roundup lawsuit.
Specific subtypes including diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and hairy cell leukemia have been accepted in MDL filings.
Some related lymphatic cancers are reviewed on a case-by-case basis by plaintiff attorneys.
What is the filing deadline for the Roundup lawsuit in 2026?
The filing deadline depends on your state’s statute of limitations, which ranges from 2 to 5 years depending on where you live.
The clock typically starts from the date you knew or reasonably should have known that your cancer was linked to Roundup.
If you believe you are approaching your deadline, treating it as urgent is the only safe course of action.
What is the difference between the Roundup class action and the mass tort lawsuits?
The Roundup cases are structured as mass tort litigation, not a traditional class action.
In a class action, all plaintiffs share one payout. In the Roundup mass tort, each plaintiff’s case is valued and resolved individually based on their personal facts.
This distinction matters because your payout reflects your specific diagnosis, exposure history, and case strength, not an equal share of a group settlement.
Where Things Stand and What You Should Do
The Monsanto Roundup lawsuit is still one of the most significant active mass tort cases in U.S. legal history. Bayer is still paying out claims. Individual trials are still happening. New cases are still being accepted.
If you used Roundup and developed Non-Hodgkin’s lymphoma, your situation deserves a real legal evaluation. The statute of limitations is the one thing that can permanently close the door on a valid claim.
Contact a plaintiff attorney who handles toxic tort cases. Most offer free consultations. Get your medical records organized. Do not wait on this.
